Schonfeld Strategic Advisors’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-74,800
| Closed | -$573K | – | 2160 |
|
|
2024
Q1 | $573K | Sell |
74,800
-33,900
| -31% | -$260K | ﹤0.01% | 1256 |
|
|
2023
Q4 | $463K | Sell |
108,700
-203,180
| -65% | -$866K | ﹤0.01% | 1231 |
|
|
2023
Q3 | $1.31M | Buy |
311,880
+242,080
| +347% | +$1.02M | 0.01% | 815 |
|
|
2023
Q2 | $389K | Buy |
69,800
+41,200
| +144% | +$229K | ﹤0.01% | 1270 |
|
|
2023
Q1 | $164K | Buy |
+28,600
| New | +$164K | ﹤0.01% | 1545 |
|